Drugs / YMN105
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07567222 | Jun → Dec 2026 expected | cancer | West China Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YMN105 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07567222 ↗ |
| Route | Subcutaneous | “subcutaneous injections of the YMN105 vaccine” NCT07567222 ↗ |